Skip to main content
Caplight Logo









eVitalRx

eVitalRx

Private
AhmedabadHealthcare & Life Scienceshttps://www.evitalrx.in/

Last Round

Seed

May 1, 2023

Total Funding Raised

$2.5M

Company Overview

eVitalRx operates in Healthcare & Life Sciences and is based in Ahmedabad. Its latest recorded funding round was a Seed round in May 2023.

eVitalRx is a healthtech company that provides a cloud-based pharmacy management ERP platform for retail and chain pharmacies to manage inventory, billing, and customer relationships.

Sector

Healthcare & Life Sciences

Verticals

Enterprise Resource Planning, Pharma Supply Chain, Retail Technology, CRM

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Services & Consulting, Payment Processing Fee

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

eVitalRx Comparables

Compare eVitalRx with similar companies based on industry and business-model similarity.

eVitalRx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medbikri
86%
Instinct Innovations Private Limited
85%
Localwell
85%
Book a demo to see all comparables

For institutional investors. Book with your work email.

eVitalRx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 1, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Chintan Patel

Founding Member & CTO at eVitalRx

Founding Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 3, 2025

    Monthly visitors increased 45% MoM to 163.1K.

  • Feb 5, 2025

    Grew 17% QoQ, from 112 to 131 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

eVitalRx Filings

Explore SEC and related filing metadata, where available.

eVitalRx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about eVitalRx's valuation, stock price, and market status.

Is eVitalRx a public or private company?

eVitalRx is a private company.

What is the current stock price of eVitalRx?

eVitalRx is a private company, so its shares have no public market price. Caplight tracks eVitalRx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is eVitalRx worth (valuation)?

Valuation information for eVitalRx is not publicly available.

Can I buy eVitalRx stock?

eVitalRx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was eVitalRx's last funding round?

eVitalRx's most recent funding round was Seed on May 1, 2023.

Who are the main investors in eVitalRx?

Investor information for eVitalRx is not publicly disclosed.

Will eVitalRx IPO soon?

No public IPO plans have been announced for eVitalRx.

How can I track eVitalRx secondary market activity?

Caplight tracks bids, offers, and trades in eVitalRx's shares on secondary markets.

Firmographic Details

HeadquartersAhmedabad
Employee Range95
Year Founded2021
Last FundingMay 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?